Role of vascular endothelial growth factor in ovarian physiology and pathology

被引:290
作者
Geva, E [1 ]
Jaffe, RB [1 ]
机构
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA
关键词
folliculogenesis; human ovary; ovarian angiogenesis; OHSS; ovarian neoplasms; ovarian pathology; ovarian physiology; PCOS; VEGF/VPF;
D O I
10.1016/S0015-0282(00)00670-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To review the current literature on the role of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in ovarian physiology and pathology. Design: A computerized search was conducted to identify relevant in vitro and in vivo studies published in English. MEDLINE, Current Contents, and the Index Medicus were searched for studies published before January 2000. Result(s): VEGF/VPF is an angiogenic factor and a potent mitogen for vascular endothelium. During reproductive life, VEGF/VPF plays a role in the cyclic growth of ovarian follicles and corpus luteum development and maintenance, mediating ovarian angiogenesis. VEGF/VPF expression and secretion are induced by both FSH and LH/hCG receptor-activated pathways. Conclusion(s): VEGF/VPF expression and production within the ovary are critical for normal reproductive function. Defects in angiogenesis may contribute to a variety of disorders including anovulation and infertility, pregnancy loss, ovarian hyperstimulation syndrome, and ovarian neoplasms. (Fertil Steril(R) 2000;74:429-38. (C) 2000 by American Society for Reproductive Medicine.).
引用
收藏
页码:429 / 438
页数:10
相关论文
共 85 条
[1]   Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome [J].
Abramov, Y ;
Barak, V ;
Nisman, B ;
Schenker, JG .
FERTILITY AND STERILITY, 1997, 67 (02) :261-265
[2]  
ADAMS J, 1985, LANCET, V2, P1375
[3]   Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries [J].
Agrawal, R ;
Conway, G ;
Sladkevicius, P ;
Tan, SL ;
Engmann, L ;
Payne, N ;
Bekir, J ;
Gampbell, S ;
Jacobs, H .
FERTILITY AND STERILITY, 1998, 70 (04) :651-658
[4]   Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries [J].
Agrawal, R ;
Sladkevicius, P ;
Engmann, L ;
Conway, GS ;
Payne, NN ;
Bekis, J ;
Tan, SL ;
Campbell, S ;
Jacobs, HS .
HUMAN REPRODUCTION, 1998, 13 (03) :651-655
[5]   Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid [J].
An, SZ ;
Bleu, T ;
Hallmark, OG ;
Goetzl, EJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) :7906-7910
[6]  
AUGUSTIN HG, 1995, AM J PATHOL, V147, P339
[7]  
BERNAL AL, 1995, J REPROD FERTIL, V104, P77
[8]  
BREIER G, 1992, DEVELOPMENT, V114, P521
[9]  
BROWN LF, 1993, CANCER RES, V53, P4727
[10]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439